A carregar...
Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
AIM: To directly compare the efficacy and toxicity of standard-dose FOLFIRINOX (sFOLFIRINOX) and modified-dose FOLFIRINOX (mFOLFIRINOX, 75% of standard-dose) for pancreatic cancer. METHODS: One hundred and thirty pancreatic cancer patients who received sFOLFIRINOX (n = 88) or mFOLFIRINOX (n = 42) as...
Na minha lista:
Publicado no: | World J Gastrointest Oncol |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Baishideng Publishing Group Inc
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6247105/ https://ncbi.nlm.nih.gov/pubmed/30487953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v10.i11.421 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|